Agreements reached under this partnership
Business alliance- 1
Standardization of quality and development of clinical protocols for the provision of musculoskeletal catheter-based treatment
- 2
Development of advanced physician education and a certification system
- 3
Raising awareness of musculoskeletal catheter-based treatment and establishing a trusted brand
- 4
Accelerating the recruitment of physicians who share the alliance's principles and the development of a physician network
- 5
Nationwide expansion of the OBL (office-based laboratory) network
- 6
Standardization of clinical processes and development of a quality management framework
- 7
Development of systems for physician recruitment and training
- 8
Support for business expansion into multiple medical specialties
These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.
| Item | Details |
|---|---|
| Name of alliance partner | Dr. Okuno Yuji (奥野祐次), Dr. Osman Ahmed (オスマン・アーメド) |
| Alliance partner's business activities | Development of musculoskeletal catheter-based treatment, Promotion of musculoskeletal catheter-based treatment in the United States, Interventional radiology (image-guided treatment) |
| Alliance partner's location | Japan, United States |
| Type of alliance | Business alliance |
| Details of the alliance | Standardization of quality and development of clinical protocols for the provision of musculoskeletal catheter-based treatment, Development of advanced physician education and a certification system, Raising awareness of musculoskeletal catheter-based treatment and establishing a trusted brand, Accelerating the recruitment of physicians who share the alliance's principles and the development of a physician network, Nationwide expansion of the OBL (office-based laboratory) network, Standardization of clinical processes and development of a quality management framework, Development of systems for physician recruitment and training, Support for business expansion into multiple medical specialties |
| Alliance start date | 17 April 2026 (commencement) |
Items this document does not state (17)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To accelerate the development of our chronic pain treatment business in the U.S. market, enhance the value of the services provided by our group by leveraging the specialized expertise of both physicians, and promote the adoption of new treatment options.